Company Filing History:
1 out of 3,923 
1 out of 2,597 
Years Active: 2020
Title: Corin Dorfmeier: Innovator in Cancer Biomarkers
Introduction
Corin Dorfmeier is a notable inventor based in Hayfield, Pennsylvania. He has made significant contributions to the field of cancer research, particularly in the development of biomarkers that predict therapeutic responsiveness to chimeric antigen receptor therapy.
Latest Patents
Dorfmeier holds a patent for "Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof." This patent discloses cancer biomarkers and methods of using them, which have the potential to enhance treatment outcomes for patients undergoing CAR therapy.
Career Highlights
Throughout his career, Dorfmeier has worked with prominent organizations, including Novartis AG and the University of Pennsylvania. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Dorfmeier has collaborated with notable colleagues such as Felipe Bedoya and Hans Bitter. These partnerships have furthered his research and innovation in cancer biomarkers.
Conclusion
Corin Dorfmeier's work in cancer biomarkers exemplifies the impact of innovative research on therapeutic advancements. His contributions are paving the way for improved cancer treatment strategies.